Gryphon Financial Partners LLC Amgen Inc Transaction History

Gryphon Financial Partners LLC

$736 Million
Q3 2024

A detailed history of Gryphon Financial Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 4,230 shares of AMGN stock, worth $1.11 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

4,230

Previous 4,022 5.17%

Holding current value

$1.11 Million

Previous $1.26 Million 8.44%

% of portfolio

0.19%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $64,351 - $70,175	208 Added 5.17%	4,230 $1.36 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $17,867 - $21,713	68 Added 1.72%	4,022 $1.26 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $72,594 - $87,631	270 Added 7.33%	3,954 $1.12 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $703,686 - $793,841	2,752 Added 295.28%	3,684 $1.06 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $203,781 - $253,000	932 New	932 $250,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $18,288 - $22,291	-81 Reduced 6.81%	1,109 $268,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $8,474 - $10,767	-37 Reduced 3.02%	1,190 $312,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1,346 - $1,518	-6 Reduced 0.49%	1,227 $276,000
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $46,834 - $52,118	203 Added 19.71%	1,233 $300,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $2,192 - $2,425	-10 Reduced 0.96%	1,030 $250,000
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $8,750 - $10,014	44 Added 4.42%	1,040 $234,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $21,863 - $25,616	-103 Reduced 9.37%	996 $212,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $20,555 - $22,804	88 Added 8.7%	1,099 $274,000
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $8,876 - $10,344	40 Added 4.12%	1,011 $252,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $865 - $1,030	4 Added 0.41%	971 $223,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $226,906 - $252,338	967 New	967 $246,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $153,810 - $203,994	-844 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $159,693 - $205,260	844 New	844 $203,000
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $72,448 - $81,675	-391 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $2,158 - $2,424	-13 Reduced 3.22%	391 $72,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $24,397 - $28,512	144 Added 55.38%	404 $69,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $43,885 - $49,033	260	260 $45,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.

Account

Gryphon Financial Partners LLC Amgen Inc Transaction History